Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04872478
Title Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Meryx, Inc.
Indications

acute lymphoblastic leukemia

acute biphenotypic leukemia

acute myeloid leukemia

Therapies

MRX-2843

Age Groups: child | senior | adult
Covered Countries USA

Additional content available in CKB BOOST